Ventria Bioscience Wins Exclusion Order Against Infringing and Mislabled Products From Wuhan Healthgen streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
ADVERTISEMENT
ADVERTISEMENT
ITC To Probe Chinese Co. After Kan. AG Warns Of IP Theft
Law360 (January 22, 2021, 10:14 PM EST) The U.S. International Trade Commission has agreed to investigate whether Wuhan Healthgen Biotechnology Corp. is infringing two patents owned by Ventria Bioscience Inc., a decision that came a little over a week after the Kansas attorney general cited concerns about Chinese economic espionage in one of several letters submitted to the commission.
The ITC agreed to launch the investigation on Jan. 15 over Ventria s bid to block Wuhan Healthgen from importing plant-derived rHSA, or recombinant human serum albumins. Plant-derived rHSA is a protein used to make immunotherapy and gene therapy drugs and vaccines, including the development of COVID-19 vaccines, according to.